| Oct 7 |
ONCY Stock Up on Regulatory Update From Breast Cancer Program
|
| Oct 7 |
Oncolytics targets accelerated approval for oncolytic virus therapy
|
| Oct 4 |
Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
|
| Sep 19 |
Oncolytics Biotech Reports "Favorable" Results for BRACELET-1 Breast Cancer Study
|
| Sep 19 |
Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
|
| Sep 6 |
Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
|
| Aug 12 |
Sernova Corp. Announces Appointment of New Chief Executive Officer
|
| Aug 2 |
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
|
| Aug 1 |
Oncolytics Biotech Inc. (ONCY) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Oncolytics Biotech GAAP EPS of -$0.10 misses by $0.03
|
